"Weight-Loss Drugs Like Zepbound Show Promise in Treating Sleep Apnea"
TL;DR Summary
Eli Lilly is funding studies to show that its weight loss drug Zepbound can also treat sleep apnea, aiming to convince insurers to cover the medication. The company has submitted promising study results to the FDA to expand the drug's approved uses beyond weight loss and diabetes, hoping to build a stronger case for broader insurance coverage.
- Drug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like Zepbound Futurism
- The New Holy Grail for Weight-Loss Drugs Is Sleep Apnea The Wall Street Journal
- Transforming sleep apnea treatment with a metabolic drug Nature.com
- Anti-Obesity Drug Zepbound May Help Treat Some Forms of Sleep Apnea Verywell Health
- Sleep Apnea Might Be the New Way to Access Ozempic and Weight Loss Drugs Sleepopolis
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
2 min
vs 3 min read
Condensed
86%
415 → 57 words
Want the full story? Read the original article
Read on Futurism